Literature DB >> 38956

The treatment of glaucoma: role of beta-blocking agents.

W P Boger.   

Abstract

The sudden development of a red painful eye with blurred vision may be an acute attack of angle closure glaucoma which requires emergency attention. Once the attack is controlled with medication, surgical intervention with a peripheral iridectomy is indicated to relieve relative pupillary block. Eyes subject to angle closure glaucoma are anatomically different with 'crowded' anterior segments. In contrast, open angle glaucoma (the more common form) may progress to near blindness without symptoms. Routine screening of intraocular pressure is, therefore, necessary to make the diagnosis before extensive irreparable damage has occurred. Surgery for open angle glaucoma carries risks of cataract and infection, and is unpredictable. Open angle glaucoma patients are usually treated chronically with specific medications. Beta-Adrenoceptor blocking agents appear to provide a significant new addition to the currently available antiglaucoma medications.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38956     DOI: 10.2165/00003495-197918010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  21 in total

1.  Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.

Authors:  M J Elliot; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

2.  Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

Authors:  I M Katz; W A Hubbard; A J Getson; A L Gould
Journal:  Invest Ophthalmol       Date:  1976-06

3.  The effect of some beta-adrenergic blockers on human intraocular pressure.

Authors:  E D el-Sharaf; E A Haroun; Z Ishaac; T M el-Shewy; A H el-Nassef
Journal:  Exp Eye Res       Date:  1974-09       Impact factor: 3.467

4.  Long-term hypotensive effect of atenolol 4% eyedrops.

Authors:  R F Brenkman
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

5.  Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.

Authors:  M J Macdonald; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1976-11       Impact factor: 4.638

6.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

7.  Comparison of ocular hypotensive effects of acetazolamide and atenolol.

Authors:  M J Macdonald; S M Gore; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

8.  Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

Authors:  W P Boger; C A Puliafito; R F Steinert; D P Langston
Journal:  Ophthalmology       Date:  1978-03       Impact factor: 12.079

9.  Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.

Authors:  K Wettrell; K Wilke; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

10.  Practolol (Eraldin) eye drops as an ocular hypotensive agent.

Authors:  J Vale; C I Phillips
Journal:  Br J Ophthalmol       Date:  1973-03       Impact factor: 4.638

View more
  1 in total

Review 1.  Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Authors:  D Ormrod; K McClellan
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.